Millennium Management
OMIC

Millennium Management’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Millennium Management’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,867
Closed -$90.5K – 6711
2024
Q1 		$90.5K Buy
5,867
+1,938
+49% +$29.6K ﹤0.01% 5595
2023
Q4 		$54.2K Sell
3,929
-19,799
-83% -$234K ﹤0.01% 5459
2023
Q3 		$271K Sell
23,728
-4,929
-17% -$91.6K ﹤0.01% 4990
2023
Q2 		$714K Buy
+28,657
New +$840K ﹤0.01% 4300
2023
Q1 		– Sell
-512
Closed -$31K – 7045
2022
Q4 		$31K Buy
+512
New +$34.3K ﹤0.01% 5929
2021
Q4 		– Sell
-15,140
Closed -$5.08M – 7527
2021
Q3 		$5.08M Buy
15,140
+8,093
+115% +$4.15M ﹤0.01% 2838
2021
Q2 		$5.81M Buy
+7,047
New +$5.46M ﹤0.01% 2556

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Millennium Management's OMIC Position: Q2 2024 in Review

Millennium Management sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2024, closing a stake of 5,867 shares — an estimated $90.5K sold.

Millennium Management first reported a position in OMIC in Q2 2021 and held it in 7 quarters. The position peaked at $5.81M in Q2 2021. 24 funds tracked by Wall St. Rank hold OMIC as of Q2 2024.

  • Millennium Management reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Millennium Management sold 5,867 Singular Genomics Systems, Inc. Common Stock shares in Q2 2024, an estimated $90.5K.
  • Millennium Management first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2021 and held it in 7 quarters.
  • Millennium Management's Singular Genomics Systems, Inc. Common Stock position peaked at $5.81M in Q2 2021.
  • 24 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.